SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001395064-20-000021
Filing Date
2020-01-24
Accepted
2020-01-24 06:16:37
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 13G/A-2 sc13ga-2_012420.htm SC 13G/A 68792
2 EXHIBIT 99.1 exhibit991-2_012420.htm EX-99.1 2190
3 EXHIBIT 99.2 exhibit992-2_012420.htm EX-99.2 9368
4 EXHIBIT 99.3 exhibit993-2_012420.htm EX-99.3 11872
  Complete submission text file 0001395064-20-000021.txt   93783
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44(0)207 400 3347
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-89732 | Film No.: 20543595
SIC: 2834 Pharmaceutical Preparations